| Financial Year |
March 31 2023 |
| Monetary Funds |
532,501,883.76 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,770,695.42 |
| Accounts Receivable |
205,084,694.56 |
| Advances to Suppliers |
66,853,626.20 |
| Other Receivables |
9,102,551.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
691,308,579.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,880,704.82 |
| Total Current Assets |
1,509,502,735.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
142,133,198.91 |
| Investment Properties |
-- |
| Fixed Assetes |
491,575,385.28 |
| Under-construction Projects |
14,130,784.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
137,850,916.85 |
| R&D expenses |
-- |
| Goodwill |
1,927,957.29 |
| Long-Term Deferred and Prepaid Expenses |
34,605,710.50 |
| Deferred Income Tax Assets |
9,976,050.99 |
| Other Non-Current Assets |
10,904,894.01 |
| Sub-Total of Non-Current Assets |
855,142,605.73 |
| Total Assets |
2,364,645,340.92 |
| Short-Term Loans |
1,773,205,980.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
98,570,500.29 |
| Accounts Received In Advance |
58,058.07 |
| Employee Compensation Payable |
28,271,484.64 |
| Taxes Payable |
11,513,628.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,027,001.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
227,209,814.85 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
2,181,979,491.21 |
| Long-term Loans |
4,927,324.59 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,620,110.86 |
| Deferred Income Tax Liabilities |
8,826,709.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
68,738,596.00 |
| Total Liabilities |
2,250,718,087.21 |
| Paid-In Capital(Or Share Stock) |
711,112,194.00 |
| Capital Surplus |
1,023,130,786.70 |
| Surplus Reserve |
245,199,949.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,911,815,936.23 |
| Minority Stockholder's Interest |
60,591,531.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
53,335,722.30 |
| Owner's Equity（Stockholder's Equity） |
113,927,253.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,364,645,340.92 |
